[1]胡一俊.依帕司他联合α-硫辛酸治疗老年糖尿病周围神经病变的效果及对氧化应激反应的影响[J].新乡医学院学报,2019,36(4):327-330.[doi:10.7683/xxyxyxb.2019.04.007]
 HU Yi-jun.Effect of epalrestat combined with α-thioctic acid in the treatment of diabetic peripheral neuropathy and its effect on oxidative stress response in senile patients[J].Journal of Xinxiang Medical University,2019,36(4):327-330.[doi:10.7683/xxyxyxb.2019.04.007]
点击复制

依帕司他联合α-硫辛酸治疗老年糖尿病周围神经病变的效果及对氧化应激反应的影响
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
36
期数:
2019年4
页码:
327-330
栏目:
临床研究
出版日期:
2019-04-05

文章信息/Info

Title:
Effect of epalrestat combined with α-thioctic acid in the treatment of diabetic peripheral neuropathy and its effect on oxidative stress response in senile patients
作者:
胡一俊
(广州中医药大学附属粤海医院内分泌科,海南 三亚 572000)
Author(s):
HU Yi-jun
(Department of Endocrinology,Yuehai Hospital Affiliated to Guangdong University of Chinese Medicine,Sanya 572000,Hainan Province,China)
关键词:
依帕司他α-硫辛酸老年糖尿病周围神经病变氧化应激
Keywords:
epalrestatα-thioctic aciddiabetic peripheral neuropathyoxidative stress
分类号:
R587.2
DOI:
10.7683/xxyxyxb.2019.04.007
文献标志码:
A
摘要:
目的 观察依帕司他联合α-硫辛酸治疗老年糖尿病周围神经病变(DPN)的临床效果及对机体氧化应激反应的影响。方法 选择2016年5月至2017年8月广州中医药大学附属粤海医院内分泌科收治的240例老年DPN患者为研究对象,按照就诊先后顺序以随机数字表法将患者分为对照组和观察组,每组120例。2组患者均予以胰岛素皮下注射控制血糖;在此基础上,对照组患者给予依帕司他50 mg,口服,每日3次,疗程4周;观察组患者在对照组治疗基础上给予α-硫辛酸0.6 g,静脉滴注,每日1次,给药2周后改为硫辛酸胶囊600 mg,口服,每日1次,治疗2周。比较2组患者的治疗总有效率及治疗前和治疗4周后的多伦多临床评分系统(TCSS)评分、神经病变自觉症状问卷(TSS)评分,并比较2组患者治疗前、治疗4周后正中神经、腓总神经的运动神经传导速度(MCV)、感觉神经传导速度(SCV)和血清超氧化物歧化酶(SOD)、还原型谷胱甘肽(GSH)水平。结果 治疗4周后,对照组和观察组患者的治疗总有效率分别为79.2%(95/120)、95.0%(114/120),观察组患者治疗总有效率显著高于对照组(χ2=7.142,P<0.05)。2组患者治疗前TCSS和TSS评分、正中神经和腓总神经MCV、SCV及血清SOD、GSH水平比较差异均无统计学意义(P>0.05)。治疗4周后,2组患者TCSS和TSS评分较治疗前显著降低,正中神经和腓总神经MCV、SCV较治疗前显著增加,血清SOD、GSH水平较治疗前显著升高(P<0.05)。治疗4周后,观察组患者TCSS、TSS评分显著低于对照组(P<0.05),正中神经和腓总神经MCV显著高于对照组(P<0.05),腓总神经SCV显著高于对照组(P<0.05),血清SOD、GSH水平显著高于对照组(P<0.05)。结论 依帕司他联合α-硫辛酸治疗老年DNP可显著增加神经传导速度,降低血清氧化应激反应水平,促进神经功能恢复。
Abstract:
Objective To observe the clinical effect of epalrestat combined with α-thioctic acid in the treatment of diabetic peripheral neuropathy (DPN) and its effect on oxidative stress response in senile patients.Methods A total of 240 senile patients with DPN admitted to Yuehai Hospital Affiliated to Guangdong University of Chinese Medicine from May 2016 to August 2017 were selected as the research objects,and the patients were divided into observation group and control group according to the order of visits,120 cases in each group.The patients in the two groups were given insulin injection by subcutaneous injection to control blood sugar.The patients in the control group were treated with epalrestat 50 mg orally,three times a day for 4 weeks.On the basis of the treatment in the control group,the patients in the observation group were treated with α-thioctic acid 0.6 g by intravenous drip,once a day;two weeks after administration,the patients were treated with thioctic acid capsule 600 mg orally,once a day for 2 weeks.The total effective rate,the Toronto clinical scoring system (TCSS) score and the total symptoms scales (TSS) score of neuropathy before and after 4 weeks of treatment were compared between the two groups.The motor conduction velocity (MCV),sensory conduction velocity (SCV) of median nerve and common peroneal nerve,and the levels of serum superoxide dismutase (SOD) and reduced glutathione hormone (GSH) were compared between the two groups before and after 4 weeks of treatment.Results After 4 weeks of treatment,the total effective rate in the control group and the observation group was 79.2%(95/120) and 95.0%(114/120),respectively.The total effective rate in the observation group was significantly higher than that in the control group (χ2=7.142,P<0.05).There was no significant difference in TCSS score,TSS score,MCV and SCV of median nerve and common peroneal nerve,the levels of serum SOD and GSH between the two groups before treatment (P>0.05).Compared with before treatment,the TCSS score and TSS score decreased significantly,the MCV and SCV of median nerve and common peroneal nerve increased significantly,and the levels of serum SOD and GSH increased significantly in the two groups after 4 weeks of treatment (P<0.05).Compared with the control group,the TCSS score and TSS score decreased significantly (P<0.05),while the MCV of median nerve and common peroneal nerve,the SCV of common peroneal nerve and the levels of serum SOD and GSH increased significantly after 4 weeks of treatment in the observation group (P<0.05).Conclusion Epalrestat combined with α-thioctic acid can significantly increase nerve conduction velocity,reduce serum oxidative stress response,and promote the recovery of nerve function in senile patients with DPN.

参考文献/References:

[1] 桑祎莹,黄仕鑫,易静,等.基于随机森林和误差反向传播神经网络的糖尿病性周围神经病变患病风险研究[J].解放军医学杂志,2018,43(10):877-881.
[2] 周丽华.血清25-羟维生素D3水平与老年2型糖尿病患者周围神经病变的相关性[J].新乡医学院学报,2017,34(2):136-138.
[3] 徐涛,郝丽梅,张焱,等.木丹颗粒联合甲钴胺治疗糖尿病周围神经病变的临床疗效[J].世界中医药,2017,12(2):266-268.
[4] 姚昌盛.依帕司他联合甲钴胺治疗老年糖尿病周围神经病变对氧化应激状态及血浆β-内啡呔水平的影响[J].北方药学,2018,15(11):21-22.
[5] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.
[6] 张艳丽.维生素B1联合甲钴胺对糖尿病周围神经病变的治疗效果[J].河南医学研究,2018,27(3):503-504.
[7] 朱志良,刘嘉悦,李丹丹.α-硫辛酸治疗老年糖尿病周围神经病变患者的疗效及作用机制[J].中国老年学杂志,2017,37(8):1908-1910.
[8] 刘宏达,邵祥忠,孙淼淼,等.丹红注射液联合单唾液酸四己糖神经节苷脂治疗糖尿病周围神经病变的疗效及对神经传导速度的影响[J].世界中医药,2018,13(12):3031-3034.
[9] 赵海燕,张长宁,黎丽萍,等.前列地尔注射液联合贝前列素钠治疗糖尿病周围神经病变67例[J].医药导报,2018,37(7):850-852.
[10] 慈慧,黄飞,陈福安,等.益气活血通络法联合参芪复方治疗糖尿病周围神经病变老年患者疗效[J].世界中医药,2017,12(5):1044-1046.
[11] 曾勇,马昌军,熊小芹.肌电图参数与糖尿病周围神经病变患者血清铁蛋白、氧化应激反应的相关性[J].海南医学院学报,2017,23(23):3215-3218.
[12] 贾莹,谢瑾,贾艳芳.凯时联用甲钴胺及α-硫辛酸对糖尿病周围神经病变患者神经电生理与氧化应激的影响[J].中国药业,2018,27(16):46-49.
[13] 高妍,李立彬,曹梅娜,等.依帕司他、α-硫辛酸联合胰岛素泵强化治疗对老年糖尿病周围神经病变患者氧化应激反应的影响[J].中国老年学杂志,2017,37(17):4254-4256.
[14] 吴敏,袁刚,管晓峰,等.α-硫辛酸治疗糖尿病周围神经病变的疗效观察[J].中华全科医学,2011,9(4):517-519.
[15] 王保法,傅莉萍,朱岚,等.α-硫辛酸治疗糖尿病周围神经病变疗效的影响因[J].浙江实用医学,2017,22(5):319-321.
[16] 李东风,章秋.硫辛酸序贯疗法联合依帕司他治疗糖尿病痛性神经病变的临床研究[J].中国全科医学,2018,21(26):3175-3178,3183.

相似文献/References:

[1]冯光勇,黄 伟.α-硫辛酸对糖尿病合并下肢动脉血管病变患者血管舒张功能及血清氧化应激因子的影响[J].新乡医学院学报,2016,33(12):1062.[doi:10.7683/xxyxyxb.2016.12.012]
 FENG Guang-yong,HUANG Wei.Effect of α-lipoic acid on vasodilatation and serum oxidative stress factor in patients with diabetes mellitus complicated with lower extremity arterial disease[J].Journal of Xinxiang Medical University,2016,33(4):1062.[doi:10.7683/xxyxyxb.2016.12.012]

更新日期/Last Update: 2019-04-05